When 246 was assessed against neurodegenerative disease targets casein kinase 1 (CK1δ) and cyclin-dependent kinase 5 (CDK5), it was found to exhibit activity against CK1δ with IC50 = 3 μM. This evidence concerns the gene CDK5 and neurodegenerative disease.